Technology

Counterfeit surgical mesh

On March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol brand name.…

Drug approval for breast cancer

The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer…

Innovations in patient-monitoring systems

With Bluetooth devices, system interfaces, and other high-tech advances, clinicians can make more accurate and timely treatment decisions. This content is for Digital Access…

Counterfeit surgical mesh

On March 11, the U.S. Food and Drug Administration issued a warning about counterfeit surgical mesh being distributed under C. R. Bard/Davol…

Drug approval for breast cancer

The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced…
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following clinical signs and symptoms should prompt a nurse to suspect acute angle glaucoma? Select all that apply.